Clinical Trial Update: Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma

View source ↗

Summary

A clinical trial update reports on biomarkers that may predict which melanoma patients respond to interferon therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Melanoma (Skin) | Status: COMPLETED